SEC Obtains Penalty, Bar From Founder, CEO of Massachusetts-based Pharma Company
August 22, 2017
August 22, 2017
WASHINGTON, Aug. 22 -- The Securities and Exchange Commission issued the following litigation release:
The Securities and Exchange Commission has obtained a final judgment against the founder and CEO of BioChemics Inc., who was charged with making false statements about collaborations with major pharmaceutical companies and the status and results of drug trials of the company's main product.
The final judgment, entered by consent on August 18, 2017 by the Honorable Mark . . .
The Securities and Exchange Commission has obtained a final judgment against the founder and CEO of BioChemics Inc., who was charged with making false statements about collaborations with major pharmaceutical companies and the status and results of drug trials of the company's main product.
The final judgment, entered by consent on August 18, 2017 by the Honorable Mark . . .